Respiratory syncytial virus prophylactic market to surpass $6 bn across 8MM in 2030
GlobalData’s latest report reveals that market growth will primarily be driven by the uptake of new monoclonal antibodies (mAbs),…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.